- Home
- TOVX vs BX Comparison
TOVX vs BX Comparison
Compare TOVX & BX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOVX
- BX
- Stock Information
- Founded
- TOVX 2001
- BX 1985
- Country
- TOVX United States
- BX United States
- Employees
- TOVX 22
- BX N/A
- Industry
- TOVX Biotechnology: Pharmaceutical Preparations
- BX Investment Managers
- Sector
- TOVX Health Care
- BX Finance
- Exchange
- TOVX Nasdaq
- BX Nasdaq
- Market Cap
- TOVX 3.2M
- BX 144.6B
- IPO Year
- TOVX 2006
- BX 2007
- Fundamental
- Price
- TOVX $1.14
- BX $170.84
- Analyst Decision
- TOVX Strong Buy
- BX Buy
- Analyst Count
- TOVX 1
- BX 20
- Target Price
- TOVX $6.00
- BX $162.72
- AVG Volume (30 Days)
- TOVX 97.3K
- BX 3.9M
- Earning Date
- TOVX 11-12-2024
- BX 01-23-2025
- Dividend Yield
- TOVX N/A
- BX 2.01%
- EPS Growth
- TOVX N/A
- BX 22.28
- EPS
- TOVX N/A
- BX 2.90
- Revenue
- TOVX N/A
- BX $11,138,276,000.00
- Revenue This Year
- TOVX N/A
- BX $51.75
- Revenue Next Year
- TOVX N/A
- BX $29.82
- P/E Ratio
- TOVX N/A
- BX $58.98
- Revenue Growth
- TOVX N/A
- BX 35.11
- 52 Week Low
- TOVX $1.14
- BX $114.88
- 52 Week High
- TOVX $17.00
- BX $200.96
- Technical
- Relative Strength Index (RSI)
- TOVX 36.15
- BX 35.77
- Support Level
- TOVX $1.23
- BX $187.74
- Resistance Level
- TOVX $1.21
- BX $192.17
- Average True Range (ATR)
- TOVX 0.07
- BX 4.84
- MACD
- TOVX 0.01
- BX -3.04
- Stochastic Oscillator
- TOVX 0.00
- BX 17.13
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.
About BX Blackstone Inc.
Blackstone is the world's largest alternative-asset manager with $1.108 trillion in total asset under management, including $820.5 billion in fee-earning assets under management, at the end of September 2024. The company has four core business segments: private equity (25% of fee-earning AUM and 30% of base management fees), real estate (35% and 39%), credit and insurance (31% and 24%), and multi-asset investing (9% and 7%). While the firm primarily serves institutional investors (87% of AUM), it also caters to clients in the high-net-worth channel (13%). Blackstone operates through 25 offices in the Americas (8), Europe and the Middle East (9), and the Asia-Pacific region (8).